Angewandte Chemie International Edition in English · 1997 · 428 citations · 134 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryMolecular OncologyDrug-receptor InteractionsIntegrin SignalingLigand BindingPeptidomimetic DesignReceptor-ligand InteractionsTargeted Cancer TherapyCell - Matrix InteractionsCell-extracellular Matrix InteractionsCell-matrix InteractionsCoagulationIntegrin Alpha Iib Beta 3 SignalingIntegrin AntagonistsIntegrin ReceptorsIntegrin-mediated Angiogenesis
Abstract Cell–cell and cell–matrix interactions play a major role in biology. An important class of surface receptors are the integrins, which exist in a number of subtypes and are involved in many biological processes, for example embryonic development, blood coagulation, osteoporosis, cancer, and regulation of the balance between proliferation and death (apoptosis) of a cell. Therefore, selective inhibition of specific integrin subtypes is of great pharmaceutical interest. It is possible to develop highly selective and active inhibitors of integrins, especially the α v β 3 subtype, by the novel procedure of spatial screening. The resulting α v β 3 antagonists exhibit activity in the nanomolar range and suppress tumor‐induced angiogenesis (formation of new blood vessels). Tissues with intact blood vessels are not influenced. This opens a promising new way for cancer therapy.
134
Integrins and other cell adhesion molecules
Steven Μ. Albelda, Clayton A. Buck · The FASEB Journal · 1990 · 2K citations
Induction of angiogenesis during the transition from hyperplasia to neoplasia
J Folkman, Karol Watson, Donald E. Ingber et al. · Nature · 1989 · 1.9K citations
Medicine, Cell Biology, Oncology +10